領航醫藥生物科技：中期報告2019-2020.pdf

1、(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)2019/20Interim Report中期報告(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)CMYCMMYCYCMYKai1576

2、8389799_InnovativePharmBio IR2019-20_Cover output.pdf 1 20/12/2019 下午6:49Contents目錄2Corporate Information公司資料4Chairmans Statement主席報告6Management Discussion and Analysis管理層討論及分析13Other Information Provided in Accordance with the Listing Rules根據上市規則披露之其他資料20Condensed Consolidated Statement of Profit o

3、r Loss and Other Comprehensive Income簡明綜合損益及其他全面收益表23Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表26Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表28Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表29Notes to the Condensed Consolidated Financial Statements簡明綜合財

4、務報表附註2Corporate Information公司資料INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED 2019/20 Interim ReportBOARD OF DIRECTORSExecutive DirectorsGao Yuan XingTang RongHuang HeNon-executive DirectorsJiang Nian(Chairman)Xiao YanWu YanminIndependent non-executive DirectorsChen WeijunZhang ZhihongWang RongliangAudit

5、 CommitteeChen Weijun(Chairman)Zhang ZhihongWang RongliangRemuneration CommitteeZhang Zhihong(Chairman)Jiang NianWang RongliangNomination CommitteeZhang Zhihong(Chairman)Jiang NianWang RongliangHONORARY CHAIRMANMao YuminCOMPANY SECRETARYPoon Hon YinREGISTERED OFFICEClarendon House2 Church StreetHami

6、lton HM 11,Bermuda董事會執行董事高源興唐榕黃鶴非執行董事蔣年（主席）肖焱鄔燕敏獨立非執行董事陳偉君張志鴻王榮樑審核委員會陳偉君（主席）張志鴻王榮樑薪酬委員會張志鴻（主席）蔣年王榮樑提名委員會張志鴻（主席）蔣年王榮樑名譽主席毛裕民公司秘書潘漢彥註冊辦事處Clarendon House2 Church StreetHamilton HM 11,Bermuda3Corporate Information公司資料2019/20年中期報告 領航醫藥及生物科技有限公司PRINCIPAL PLACE OF BUSINESS IN HONG KONGUnit No.2111,21/F.Wes